Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Patient perception of anticoagulant treatment for stroke prevention (RE-SONANCE study).
Vinereanu D, Napalkov D, Bergler-Klein J, Benczur B, Ciernik M, Gotcheva N, Medvedchikov A, Põder P, Simic D, Skride A, Tang W, Trusz-Gluza M, Vesely J, Vishnepolsky T, Vrabec M. Vinereanu D, et al. Among authors: poder p. Open Heart. 2020 Mar 24;7(1):e001202. doi: 10.1136/openhrt-2019-001202. eCollection 2020. Open Heart. 2020. PMID: 32257246 Free PMC article.
Patient perceptions of anticoagulant treatment with dabigatran or a vitamin K antagonist for stroke prevention in atrial fibrillation according to region and age: an exploratory analysis from the RE-SONANCE study.
Vinereanu D, Napalkov D, Bergler-Klein J, Benczur B, Ciernik M, Gotcheva N, Medvedchikov A, Põder P, Simić D, Skride A, Tang W, Trusz-Gluza M, Vesely J. Vinereanu D, et al. Among authors: poder p. J Thromb Thrombolysis. 2021 Nov;52(4):1195-1206. doi: 10.1007/s11239-021-02450-2. Epub 2021 Apr 30. J Thromb Thrombolysis. 2021. PMID: 33929686 Free PMC article.
Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction. A randomized, placebo-controlled, double-blind study (RUSSLAN).
Moiseyev VS, Põder P, Andrejevs N, Ruda MY, Golikov AP, Lazebnik LB, Kobalava ZD, Lehtonen LA, Laine T, Nieminen MS, Lie KI; RUSSLAN Study Investigators. Moiseyev VS, et al. Among authors: poder p. Eur Heart J. 2002 Sep;23(18):1422-32. doi: 10.1053/euhj.2001.3158. Eur Heart J. 2002. PMID: 12208222 Clinical Trial.
Navigating between Scylla and Charybdis: challenges and strategies for implementing guideline-directed medical therapy in heart failure with reduced ejection fraction.
Seferović PM, Polovina M, Adlbrecht C, Bělohlávek J, Chioncel O, Goncalvesová E, Milinković I, Grupper A, Halmosi R, Kamzola G, Koskinas KC, Lopatin Y, Parkhomenko A, Põder P, Ristić AD, Šakalytė G, Trbušić M, Tundybayeva M, Vrtovec B, Yotov YT, Miličić D, Ponikowski P, Metra M, Rosano G, Coats AJS. Seferović PM, et al. Among authors: poder p. Eur J Heart Fail. 2021 Dec;23(12):1999-2007. doi: 10.1002/ejhf.2378. Epub 2021 Dec 13. Eur J Heart Fail. 2021. PMID: 34755422 Free article. Review.
23 results